| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.1M | +6658.5% |
| Cost of Revenue | $23.2M | — |
| Gross Profit | $1.8M | +437.3% |
| R&D Expense | $698K | — |
| SG&A Expense | $58K | +3840.0% |
| Operating Income | -$13.2M | +12.0% |
| Pre-tax Income | -$11.7M | +61.2% |
| Income Tax | $73K | — |
| Net Income | $14.2M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.3M | +413.6% |
| Short-term Investments | $2.2M | — |
| Accounts Receivable | $9.1M | — |
| Inventory | $73K | — |
| Current Assets | $72.7M | +368.6% |
| Total Assets | $91.7M | +475.3% |
| Current Liabilities | $7.2M | +39.5% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Investing Cash Flow | -$11.2M | — |
| Financing Cash Flow | $69.3M | +303.3% |
| -84.0% |
| EPS (Diluted) | -$0.21 | -109.0% |
| Total Liabilities |
| $10.8M |
| +50.0% |
| Stockholders' Equity | $81.4M | +827.8% |